|
C12ORF41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.987600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.697400E-01 |
| Normal-vs-Stage2 |
4.447800E-01 |
| Normal-vs-Stage3 |
1.052420E-02 |
| Normal-vs-Stage4 |
1.082470E-02 |
| Stage1-vs-Stage2 |
7.541000E-01 |
| Stage1-vs-Stage3 |
1.275900E-02 |
| Stage1-vs-Stage4 |
1.473810E-02 |
| Stage2-vs-Stage3 |
2.117200E-01 |
| Stage2-vs-Stage4 |
1.488190E-01 |
| Stage3-vs-Stage4 |
6.803000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.672000E-02 |
| Normal-vs-AfricanAmerican |
5.230000E-01 |
| Normal-vs-Asian |
2.500800E-01 |
| Caucasian-vs-AfricanAmerican |
6.634200E-01 |
| Caucasian-vs-Asian |
1.076510E-03 |
| AfricanAmerican-vs-Asian |
1.885570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.678800E-01 |
| Normal-vs-Female |
3.735800E-02 |
| Male-vs-Female |
1.073160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.930200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.278420E-01 |
| Normal-vs-Age(61-80Yrs) |
8.639000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.393600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.551200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.206450E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.128970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.364770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.763000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.947400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.361500E-03 |
| Classical-VS-Follicular |
2.374400E-01 |
| Classical-VS-Other |
7.589400E-01 |
| Classical-VS-Normal |
4.956600E-01 |
| Tall-VS-Follicular |
4.853600E-02 |
| Tall-VS-Other |
6.880200E-02 |
| Tall-VS-Normal |
8.412800E-04 |
| Follicular-VS-Other |
5.398000E-01 |
| Follicular-VS-Normal |
1.301600E-01 |
| Other-VS-Normal |
9.753600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.567400E-01 |
| Normal-vs-N1 |
9.299700E-02 |
| N0-vs-N1 |
3.976200E-01 |
|
|
